
The United States Supreme Court held in Riegel v. Medtronic, Inc. in February 2008 that plaintiffs are barred from alleging common-law claims under state law when challenging the safety and effectiveness of medical devices if the Food and Drug Administration (FDA) has given those devices "premarket approval."
In Riegel, plaintiff brought suit in a








Comment Preview